Eczema Awareness Month


October is Eczema Awareness Month, and Spokane Dermatology Clinic is embarking on an awareness campaign! We hope to empower our patients to take control of their health while raising awareness for our neighbors who are affected by eczema.



Eczema is a condition where patches of skin become inflamed, itchy, red, cracked, and rough. Blisters may sometimes occur. Different stages and types of eczema affect 31.6 percent of people in the United States.

The word "eczema" is also used specifically to talk about atopic dermatitis, the most common type of eczema. "Atopic" refers to a collection of diseases involving the immune system, including atopic dermatitis, asthma, and hay fever. Dermatitis is an inflammation of the skin.

Some people outgrow the condition, while others will continue to have it throughout adulthood.


The symptoms of atopic dermatitis can vary, depending on the age of the person with the condition.

Atopic dermatitis commonly occurs in infants, with dry and scaly patches appearing on the skin. These patches are often intensely itchy.

Most people develop atopic dermatitis before the age of 5 years. Half of those who develop the condition in childhood continue to have symptoms as an adult.

However, these symptoms are often different to those experienced by children.

People with the condition will often experience periods of time where their symptoms flare up or worsen, followed by periods of time where their symptoms will improve or clear up.going into complete remission.



1) Make an appointment at SDC

If you suspect that you may have some form of eczema, make an appointment with Dr. Reese for an examination here at Spokane Dermatology Clinic. Even though the condition itself is not yet curable, there should be a particular treatment plan to suit each person with different symptoms. Even after an area of skin has healed, it is important to keep looking after it, as it may easily become irritated again.

2) Participate in Research


Eczema Clinical Research Study

Our partners at Premier Clinical Research are evaluating potential new medications that are intended to reduce severity and symptoms (including itching) in patients with eczema.

Qualified participants may receive:

• Study-related medical care and treatment at no cost
• Compensation for time and travel.

Jonathan McClung